Nasdaq: DFTX
Definium Therapeutics insiders
The officers, directors and 10% owners of Definium Therapeutics, Inc. who hold the most stock, valued at the live DFTX price.
$29.48
DFTX today +$360K (+1.24%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 8
- Their DFTX stock
- $138M
- Market value
- $4.04B
- Held by ranked insiders
- 3.41%
Insiders by value of DFTX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Robert Barrow | Chief Executive Officer | 2,213,090 | $65.2M | 1.62% | 2106th |
| 2 | Daniel Karlin | Chief Medical Officer | 792,846 | $23.4M | 0.58% | 4620th |
| 3 | Mark Sullivan | Chief Legal Officer | 494,228 | $14.6M | 0.36% | 6591st |
| 4 | Brandi Roberts | Chief Financial Officer | 394,528 | $11.6M | 0.29% | 7847th |
| 5 | Matthew T. Wiley | Chief Commercial Officer | 359,036 | $10.6M | 0.26% | 8414th |
| 6 | Schond Greenway | Chief Financial Officer | 211,057 | $6.2M | 0.15% | 12446th |
| 7 | Miri Halperin Wernli | Executive President | 202,405 | $6.0M | 0.15% | 12833rd |
| 8 | Roger Adsett | Director | 3,555 | $105K | <0.1% | 6666th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Definium Therapeutics; see each profile for the filing.